Abstract
Due to electrical features of the tissue, such as impedance, which have a significant impact on irreversible electroporation (IRE) function, the administration of glucose solution 5% (GS5%) through the hepatic artery would focus IRE on scattered liver tumors. By creating a differential impedance between healthy and tumor tissue. This study aimed to determine the effects of the GS5% protocol on healthy liver tissue and its safety. 21 male Athymic nude rats Hsd: RH-Foxn1mu were used in the study. Animals were split into two groups. In group 1, a continuous infusion through the gastroduodenal artery of GS5% was performed to measure the impedance with a dose of 0.008 mL/g for 16 min. In group 2, the animals were divided into two subgroups for infusions of GS5%. Group 2.1, at 0.008 mL/g for 16 min. Group 2.2 at 0.03 mL/g for 4 min. Blood samples were collected after anesthesia has been induced. The second sample, after catheterization of the artery, and the third after the GS5% infusion. All the animals were sacrificed to collect histological samples. The survival rate during the experiment was 100%. A considerable impact on the impedance of the tissue was noticed, on average up to 4.31 times more than the baseline, and no side effects were observed after GS5% infusion. In conclusion, impedance alteration by Glucose solution infusion may focus IRE on tumor tissue and decrease IRE’s effects on healthy tissue.
Similar content being viewed by others
Introduction
Electroporation (EP) is one of the most garnered interests in surgery and biomedicine. Scientists are trying to develop it since it is a promising non-thermal technique to minimize the invasion degree of ablation surgeries1,2,3,4. Depending on the desired procedure, EP could be reversible (RE), when the permeabilization in cells is temporal it can be a functional tool in other aspects of therapy, such as gene therapy and electrochemotherapy5,6,7,8. If the involved electric field is beyond the threshold of cells, they would be unable to shut the pores, thus leading to cell death due to the loss of homeostatic mechanisms and creating permanent instability in the cell membrane. This phenomenon is called irreversible electroporation (IRE)9 which can destroy tumor cells by localized non-thermal procedures. Regarding using electrical fields to make changes in the cell membrane permeability, the permeabilization of the cell membrane is exceedingly increased through the disturbance of Na+ and K+ gradient10, it can be a functional tool in other aspects of therapy, such as gene therapy and electrochemotherapy5,6,7,8. EP can destroy tumor cells by localized non-thermal procedures. Cell death occurs because of a disordered Ca2+ signaling system, responsible for producing failed regulation of the energy contribution in cells by depolarization of the cell membrane11,12. Damage to membranes may result from EP, which also promotes cell repair. EP damages membrane proteins by generating lipid peroxidation, which results in the emergence of membrane pores. Because several cell death processes overlap, it is still unclear what is the main cause of cell death following electroporation. When the plasma membrane is disrupted, Ca2+ ions from the extracellular environment might enter the cell, altering intracellular calcium homeostasis. Since Ca2+ is a universal carrier of biological information, EP can activate several cell signaling pathways, such as stress or cell death pathways Even if the resulting pores are sealed again13.
In IRE, the electrical field destroys target tissues by inducing short high electric pulses in microseconds widths (80–100 µs)14,15. The IRE method does not preserve the surrounding healthy tissue that is very dependent on the Ohmic Characteristic of tissue under the treatment16,17,18,19,20. However, it is a non-thermal technique to spare the extracellular matrix but induces apoptosis in healthy and tumor tissue where the electric field applies21,22.
Achieving perfect irreversible electroporation requires precision and improving the selectivity of the process23 to raise the concentration of the electric field on target cells. Interestingly, hepatic tumor nodules lack sinusoids and are only supplied with blood from the hepatic artery24,25,26. This fact is currently used for identifying tumors by injection of contrast agents with CT or MRI. Therefore, a hypersaline infusion (HI) through the portal vein or a non-electrolyte solution (for instance, glucose solution 5%) through de hepatic artery would change the electrical conductivity of the healthy and tumor tissue of the liver so that, when a potential difference is applied between the opposite sides of the liver, the electrical field magnitude in the tumors would be significantly larger than in the rest of the tissue. Thus, it would be possible to cause electroporation in tumor cells and avoid this phenomenon in healthy liver tissue27.
In our previous studies, we infused HI through the portal vein to concentrate the electric field in tumor tissue, as we were able to observe conductivity changes of the liver up 1.4 folds higher than tumor tissue23, which could focus the treatment on tumor tissue and reduce unwanted damages in the healthy tissue27. These results proved that selective electroporation would be available while the electrical field is modified by conductive fluids such as HI through the portal vein23. However, utilization of HI in the portal system leads to a significant risk of possible lethal cytolysis and acidosis28. For this reason, we propose a new protocol by infusing deionized solution (Glucose) (Fig. 1) into the hepatic artery29 to observe changes in the impedance of the tissue. The present study aims to increase the impedance of healthy liver tissue by infusing a low conductivity compound (GS5%) through the hepatic artery and assess its immediate safety.
Results
The glucose infusion method is safe
Infusion of glucose solution was uneventful in all the animals with no repercussions on temperature, heart rate, and oxygen saturation during infusion. However, in group 1, four rats were sacrificed because catheterization was impossible, attributable to the small size of their artery’s diameter before the initiation of the infusion. Technically, the survival rate during the experiment was one hundred percent (7 out of 7).
Analysis of the biochemical parameters of blood samples
Blood analytical results and body temperature in the animals were evaluated for both groups, G2.1, and G2.2, at three stages, post-induction of anesthesia, pre-infusion, and post-infusion of GS5%. All the blood parameter data are shown in Table 1.
The mean catheterization length in groups G2.1 and G2.2 were respectively 46.00 ± 24.10 and 41.50 ± 8.89 min. The catheterization process in one of the rats in group G2.1 was quite challenging, and it took 80 min to complete.
GS5% infusion increases Impedance in the healthy hepatic parenchyma
GS5% infusion through the hepatic artery changes healthy tissue impedance. As expected, hepatic tissue impedance was influenced by GS5%. The graph is made by 8 animals, and they are the best cases among sixteen animals, included group G1.1. The mean of maximum hepatic impedance after the infusion for 16 min was up to 4.31 times higher than the mean of minimum impedance baseline. In one of the cases, maximum impedance increased to 6.59 times more than baseline after infusion of GS5% and then, slightly decreased after the termination of infusion and removal of clamps (Fig. 2).
Histopathology evaluation
At autopsy, macroscopically all the animals showed some degree of pulmonary edema attributable to “postmortem changes”. Four rats have had areas in their lung with alveolar collapse. In all the rats, there are some areas with rupture of the hepatic parenchyma with hemorrhages, and three rats have ruptured capsules. The capsule and parenchyma ruptures were attributable to the manipulation and exteriorization of the liver. The rest of the organs were without significant macroscopic alterations.
In the histopathological study of the liver, all rats had diffused areas of discoloration in their hepatic parenchyma, and it was paler than the other areas. Also, in these areas, there were hepatocytes with cellular degeneration (some without nuclei and others with hyperchromatic nuclei), although they preserved the cellular structure. The hepatic sinusoids in these areas did not have many red blood cells. Obstruction in vessels was infrequently scattered throughout healthy hepatic tissue. No alterations were presented in the cellular component or architecture after the infusion (Fig. 3).
In the lungs, diffuse alveolar edema was observed in all animals. No abnormalities were observed in the spleen, kidney, heart, or brain.
Stationary simulation of electric field distribution
IRE model applied, in 3 tumors in 3 different positions without or with Glucose infusion through the artery at minimum, maximum effects and its corresponding numerical simulation obtained from the received electric field in tumoral tissue. In the first case (without Glucose infusion), there is not selective effect on scattered tumoral nodules. Nevertheless, in Glucose infusion through the Artery, there is an increase on the electric field on scattered tumors (meaning a preferential Electrical field effect on these nodules) because of the increase in healthy tissue conductivity (Fig. 4).
Discussion
To the best of our knowledge, it is the first study in which an isotonic solution is infused through the arterial inflow to change the electrical conductivity of a specific environment. It could be a rather advantageous situation in the electroporation of liver tumors regarding the lack of sinusoids that tumors display. Both safety and changing conductivity has been demonstrated.
The tissue's physical properties, like impedance, could be a suitable factor to reduce the electrical field throughout the tissues and decrease the damage to the healthy tissues besides the tumor30. Following our previous studies on changes in liver tissue conductivity and its safety, we started exploring various biocompatible materials with low toxicity and capable of manipulating tissue impedance to observe the results in the electrical impedance of the tissue23,27,31. Finally, GS5% was selected for model32. Due to the molecular dissolution of the glucose, glucose does not dissociate into ions in water and hence could not offer the electrical charge. This property, together with the isotonic nature of its solution causes, a considerable impact on the impedance of the tissue with the lowest possible side effects during its liver infusion.
According to the results, we altered electrical impedance in hepatic tissue on an average of up to 4.31 times more than basal impedance. However, individually there was a case with 6.59 times increase in the maximum point. This result could be a prospective for further studies to make changes in the neighborhood environment of hepatic tumors and healthy tissue for allowing the electroporation to distinguish healthy hepatic versus tumoral tissue by differential electrical impedance in future studies. These results are consistent with the results of the simulation of the experiment with the numerical analysis of the data. Contrary to the previous studies in which the infusion of hypersaline caused sharp changes in the relative conductivity of healthy and tumor tissue23, the slope of impedance changes in this study is slow both during and at the end of infusion, which can lead to a larger therapeutic window for electroporation. Even though four rats of group 1 were sacrificed before catheterizing and outed from the experiment due to having a too-small hepatic artery, there were no failed cases during the infusion. These results have shown that a 5% glucose solution was a good choice for replacing a hypersaline solution to make a differential electrical environment in the liver tissue with lower risk and higher efficiency.
The infusion method in previous studies was performed through the portal vein23,28 due to the presence of various tissues (healthy and tumor). Besides, it was used as a conductive substance to produce higher conductivity in healthy tissue versus tumors. According to many studies, 70% of blood flow in healthy tissue is through the portal vein and 30% through the hepatic artery while the supplied blood in the tumor arrives through the hepatic artery25,26,29,33. Therefore, in this study, the hepatic artery was chosen to be engaged to infuse glucose solution. The hypothesis has been that with glucose infusion the impedance changes for both tissues will rise. If there were a tumor, this surge of impedance would be much higher than the healthy tissue and, subsequently, it will create a suitable and long therapeutic window for electroporation. This could be assessed in future studies.
Another discussible finding was blood parameters during the procedure. Mean of post-induction values for each parameter considered as basal concentration in blood (Table 1). Then it was possible to analyze them to see any significant difference between the two stages of pre-infusion and post-infusion with basal values. Statistical analyses have shown there is a difference between blood parameters in post-induction and post-infusion. As expected, hyperglycemia has caused by the large amount of glucose that we administered, especially in group 2.2. The peak of hyperglycemia in animals that are not diabetic does not cause any problems. Lobo showed that a bolus of 1 L of dextrose 5% induces transient hyperglycemia and then, two hours after the infusion, glycemia levels were normalized in healthy people. Moreover, a large number of infused fluids and glucose were voided by urine34.
The basal pH in both groups was significantly different from post-infusion. The changes in pH, pCO2, and HCO3 observed in our study are associated with anesthesia since the respiratory depression of inhalation anesthesia produces slight hypoxia and hypercapnia, caused to respiratory acidosis35,36.
In histopathology results, it has been observed that hepatic congestion occurs mainly due to the large volume of injected fluids (Fig. 3). Although we have not done a long-term study, based on previous experience with the hypersaline solution, which has been prescribed in very high volumes23,27,28, we conclude that in the long-term, there will be no problem or alteration in the liver parenchyma. The initial cytolysis observed after hypersaline injection in the earlier study was compensated by rapid liver regeneration at three weeks. Anesthesia could lead to respiratory depression and alveolar collapse. Along with respiratory depression, atelectasis can occur with the administration of oxygen of more than 21%37,38,39. During the liver catheterization of the gastroduodenal artery, a rupture occurred in the liver parenchyma and caused bleeding, which has been described in the histopathology. Regarding these reasons, we believe that alterations are not created by the administration of glucose solution.
Given that no changes in liver structure were observed in the present study, we deem that hepatic congestion resolves or improves over time.
According to the shortcomings of this essay, it counsels future studies to employ larger animals, like rabbits, to avoid complex catheterizing processes due to physiological limitations. Moreover, it would be great to apply the procedure to a tumoral animal model regarding our result. For this reason, our group is working on a tumoral animal model on rabbits to facilitate surgical operation and test this hypothesis. Our trial was limited to examining the status of biochemical factors and blood gases in pre-surgical, pre-infusion, and post-infusion. Long-term monitoring is essential in forthcoming essays to treat possible imbalances caused by infusion, protocol, and anesthesia. These are preliminary results; more reports require to perform.
In conclusion, this study aimed to assess the feasibility and safety of selectively increasing healthy hepatic impedance by infusion of glucose solution through the Hepatic artery as a relief to increase the electric field relatively in scattered tumoral nodules with transhepatic IRE in future studies. Infusion of its solution in the liver could have a considerable impact on the impedance of the tissue. GS5% could be considered a highly valuable solution for decreasing the conductivity of healthy liver tissue for protection against IRE side effects when it is applied to tumor tissue (without portal irrigation) due to its low conductivity and the fact that it is easily eliminated by the kidney and high biocompatibility characters.
Some limitations of the study should also be addressed: (1) this is a preliminary study with a small sample size in the best conditions and we have discarded some cases in which arterial catheterization was impossible; (2) this study has been done in healthy liver. Confirmation of the real benefit into real tumor models should require further experiments.
Materials and methods
All features of the study had the endorsement of the Ethics Committee on Animal Research of the Government of Catalonia (GE26077/D045906). All the animal experiments in the study had driven following directives 2010/63/ EU of the European Parliament and Council of 22 September 2010, the protection of animals for experimental and scientific approaches. The authors declare that the animal results of the study are reported following ARRIVE guidelines (https://arriveguidelines.org).
Animal model
The animal model pondered for the study consisted of 21 Athymic nude rats Hsd: RH-Foxn1mu rat (eleven males and ten females), which were eight-week-old at the time of the experiment. The mean and standard deviation of weight in the rats were 456.2 ± 9.32 g and 265.60 ± 14.55 g, males, and females respectively. All the rats were kept under qualified circumstances and alimented with a laboratory animal ratio and water (ad libitum). All animals were monitored for pain, distress, and discomfort recognition in experimental animals by following Morton and Griffiths’ guidelines40. Based on our prior studies, animals were split into two groups. In the first group (group 1) (seven males and four females), a continuous infusion through the gastroduodenal artery of GS5% was performed to measure the impedance with a dose of 0.008 mL/g for 16 min, average total volume was 58.6 ± 0.09 mL. In the second group (group 2) (four males and six females), the animals were divided into two subgroups for infusions of GS5%. First, like group one, at 0.008 mL/g for 16 min (group 2.1) and the other at 0.03 mL/g for 4 min (group 2.2). Where the mean of total volume for males and females 54.48 ± 2.4 and 30.8 ± 1.26 mL respectively. Group two were employed to compare biochemical and histopathological alteration before and after SG5% infusion and to investigate the safety in different doses and speeds. (Four times higher and four times faster).
Blood tests
Three blood tests were collected from animals during the procedure. The first is once after anesthesia has been induced, the second after catheterization of the artery, and the third after the GS5% infusion. Blood sample extraction was performed through the facial vein with a volume of 0.15 mL for each extraction while the temperature was controlled. The electrolytes (Na+ and K+), Glucose, and blood gases (HCO3, BE, pH, pCO2, pO2) were analyzed immediately with an I-STAT device (Abbott Point of Care Inc, Princeton, NJ, USA).
Anesthesia, surgery procedure, and infusion
General anesthesia was satisfactorily performed by inhaling isoflurane 4% (IsoVet, BBraun) for induction and 2.5% for maintenance with 100% O2 at 0.8 L/min and, subcutaneous analgesia was performed with buprenorphine 0.05 mg/kg (Buprecare, Ecuphar, Spain) and meloxicam 1 mg/kg (Metacam, Boehringer Ingelheim Vetmedica GmBH, Spain). Pulse oximetry, ECG, and temperature were monitored every 5 min during the surgery and infusion procedure using a multi-parameter monitor (VetCare, BBraun, Spain). The abdominal area of each rat was shaved, surgical asepsis routines were properly applied and then, the middle laparotomy was carried out. Due to the placement of sterile gauze in the dorsal region of the rats, after the abdominal incision, the right and left median hepatic lobes were exteriorized. Celiac, hepatic, and gastroduodenal arteries plus the portal vein were accurately identified. Through the gastroduodenal artery, one French catheter (Instech Laboratories, USA) was inserted into the hepatic artery to perform the infusion protocol. The used catheter was fixed at the chosen vessel with non-absorbable Polypropylene Suture 6/0 (Prolene). Surgery length from anesthesia induction until completion of catheterization was controlled. Before the infusion, the celiac artery was clamped with stainless steel micro-vascular clamp (AgnTho's AB, Sweden). The rats were neither intubated nor mechanically ventilated.
Once the gastroduodenal artery was catheterized, the right and left median hepatic lobes were returned to physiological position and the electrodes were placed in the right and left hepatic lobe. Subsequently, the animals were infused with GS5% (Glucosado 5% Braun, BBraun, Spain) using an infusion pump (Fig. 5).
When the infusion protocol was completed, all the rats were sacrificed according to “modified Morton and Griffiths criteria” to assay signs of pain or irritation40 by injection of sodium pentobarbital (Dolethal, Vetoquinol, Spain).
Electrical impedance measurement
Hepatic impedances were accurately measured by using Tetrapolar electrodes with a Kelvin connection, which consisted of four surgical steel needles with a diameter of 0.2 mm, separated by 1 mm and with a penetration depth of 3 mm27 (Fig. 6). The standard setup included two Keysight E498A impedance analyzers with a bandwidth between 20 Hz and 300 kHz. The impedance analyzers were monitored by MATLAB software via USB communication. There were two electrodes inserted at the right and left lobe of the liver, with four needle shapes and the most superior stability and completely fixed in the tissue. Electrical impedance was measured at ten excitation frequencies from 1 to 100 kHz at a rate of 0.5 Hz (Fig. 5).
Histopathological samples
For the histological studies, at necropsy, the brain, lung, heart, liver, spleen, and kidneys were collected from rats. Tissue samples were immediately removed and fixed in formaldehyde and embedded in paraffin. Paraffin sections of tissues were cut into 3 μm thickness and stained with Hematoxylin and Eosin (HEOS)41 for light microscopy examination.
Statistical analyses
All statistical analyses were developed with SPSS statistical software package (SPSS, version 21, IBM, Armonk, NY, USA). Normality was tested using the Shapiro–Wilk statistic. For bio-parameters of blood samples, Mann–Whitney Test and Wilcoxon test were used for non-parametric data to make pairwise comparisons of the impedance of healthy tissue before and after GS5% infusion, in both groups. A P-value of < 0.05 was considered statistically significant.
The FEA model
COMSOL Multiphysics 5.3a software (COMSOL Inc., Burlington, MA, USA) was used to simulate stationary simulation of electric field distribution in tumor in the FEA model with the injection of 5% solution at the basal impedance of tissue (impedance in tumor tissue is Lower than the healthy tissue)42,43,44. A minimum increase of impedance (1.7 times) and maximum increase of impedance (6.6 times). Applied 500 V to a 0.5 cm thick, so in an ideal situation an average field of 1000 V/cm would be expected42,44. Tissue conductivity has been made reliant on the electric field module to improve model accuracy. The parameters they utilized are shown in the Table 2.
Data availability
The datasets used and analyzed during the current study are available from the corresponding author upon reasonable request. Any restrictions on the availability of materials or information must be disclosed to the editors at the time of submission.
References
Bertacchini, C. et al. Design of an irreversible electroporation system for clinical use. Technol. Cancer Res. Treat. 6, 313–320 (2007).
Zhang, Y. et al. MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: Preclinical feasibility studies in a rodent model. Radiology 256, 424–432 (2010).
Martin, R. C. G., McFarland, K., Ellis, S. & Velanovich, V. Irreversible electroporation in locally advanced pancreatic cancer: Potential improved overall survival. Ann. Surg. Oncol. 20, 443–449 (2013).
Sánchez-Velázquez, P. et al. Long-term effectiveness of irreversible electroporation in a murine model of colorectal liver metastasis. Sci. Rep. 7, 1–8 (2017).
Serša, G., Čemažar, M. & Miklavčič, D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res. 55, 3450–3455 (1995).
Miklavčič, D. et al. Electrochemotherapy: Technological advancements for efficient electroporation-based treatment of internal tumors. Med. Biol. Eng. Comput. 50, 1213–1225 (2012).
Calvet, C. Y. & Mir, L. M. The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Rev. 35, 165–177 (2016).
Ramirez, L. H. et al. Electrochemotherapy on liver tumours in rabbits. Br. J. Cancer. 77, 2104–2111 (1998).
Mir, L. M. et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur. J. Cancer Suppl. 4, 14–25 (2006).
Clausen, T. & Gissel, H. Role of Na+, K+ pumps in restoring contractility following loss of cell membrane integrity in rat skeletal muscle. Acta Physiol. Scand. 183, 263–271 (2005).
Rols, M. P. & Teissié, J. Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys. J. 58, 1089–1098 (1990).
Gissel, H., Lee, R. C. & Gehl, J. Electroporation and cellular physiology. in Clinical Aspects of Electroporation 9–17 (Springer, 2011). https://doi.org/10.1007/978-1-4419-8363-3_2.
Batista Napotnik, T., Polajžer, T. & Miklavčič, D. Cell death due to electroporation—A review. Bioelectrochemistry 141, 107871 (2021).
Zhang, N. et al. Irreversible electroporation: An emerging immunomodulatory therapy on solid tumors. Front. Immunol. 12, 1–12 (2022).
Cannon, R., Ellis, S., Hayes, D., Narayanan, G. & Martin, R. C. G. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J. Surg. Oncol. 107, 544–549 (2013).
Ivorra, A., Villemejane, J. & Mir, L. M. Electrical modeling of the influence of medium conductivity on electroporation. Phys. Chem. Chem. Phys. 12, 10055–10064 (2010).
Lv, Y. et al. A fundamental theoretical study on the different effect of electroporation on tumor blood vessels and normal blood vessels. Bioelectrochemistry 144, 1–9 (2022).
Rubinsky, B., Onik, G. & Mikus, P. Irreversible electroporation: A new ablation modality—Clinical implications. Technol. Cancer Res. Treat. 6, 37–48 (2007).
Gudvangen, E., Kim, V., Novickij, V., Battista, F. & Pakhomov, A. G. Electroporation and cell killing by milli- to nanosecond pulses and avoiding neuromuscular stimulation in cancer ablation. Sci. Rep. 12, 1763 (2022).
Murphy, K. R. et al. High-frequency irreversible electroporation brain tumor ablation: Exploring the dynamics of cell death and recovery. Bioelectrochemistry 144, 108001 (2022).
Hofmann, F. et al. Electric field pulses can induce apoptosis. J. Membr. Biol. 169, 103–109 (1999).
Maor, E. & Rubinsky, B. Endovascular nonthermal irreversible electroporation: A finite element analysis. J. Biomech. Eng. 132, 031008 (2010).
Pañella, C. et al. Focused transhepatic electroporation mediated by hypersaline infusion through the portal vein in rat model. Preliminary results on differential conductivity. Radiol. Oncol. 51, 415–421 (2017).
Isozaki, T. et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 229, 798–805 (2003).
Liu, Y. & Matsui, O. Changes of intratumoral microvessels and blood perfusion during establishment of hepatic metastases in mice. Radiology 243, 386–395 (2007).
Dezso, K. et al. Development of arterial blood supply in experimental liver metastases. Am. J. Pathol. 175, 835–843 (2009).
Castellví, Q., Sánchez-Velázquez, P., Berjano, E., Burdío, F. & Ivorra, A. Selective electroporation of liver tumor nodules by means of hypersaline infusion: A feasibility study. IFMBE Proc. 45, 821–824 (2015).
Pañella, C. et al. Hypersaline infusion protocol through the portal vein may focus electroporation on tumor tissue, but is it really safe? Preliminary results. Clin. Surg. 4, 1–5 (2019).
Breedis, C. & Young, G. The blood supply of neoplasms in the liver. Am. J. Pathol. 30, 969–977 (1954).
Qasrawi, R., Silve, L., Burdío, F., Abdeen, Z. & Ivorra, A. Anatomically realistic simulations of liver ablation by irreversible electroporation: impact of blood vessels on ablation volumes and undertreatment. Technol. Cancer Res. Treat. 16, 783–792 (2017).
Buy, X., Basile, A., Bierry, G., Cupelli, J. & Gangi, A. Saline-infused bipolar radiofrequency ablation of high-risk spinal and paraspinal neoplasms. Am. J. Roentgenol. 186(5 Suppl), S322–6 (2006).
Medicines, E. & Kingdom, U. Intravenous sugar solution. 2–4 (2019). https://en.wikipedia.org/wiki/Intravenous_sugar_solution.
Kitao, A., Zen, Y., Matsui, O., Gabata, T. & Nakanuma, Y. Hepatocarcinogenesis: Multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography—Radiologic-pathologic correlation. Radiology 252, 605–614 (2009).
Lobo, D. N. et al. Dilution and redistribution effects of rapid 2-litre infusions of 0.9% (w/v) saline and 5% (w/v) dextrose on haematological parameters and serum biochemistry in normal subjects: A double-blind crossover study. Clin. Sci. 101, 173–179 (2001).
Whiteside, G. T. et al. Robustness of arterial blood gas analysis for assessment of respiratory safety pharmacology in rats. J. Pharmacol. Toxicol. Methods 78, 32–41 (2016).
Svorc, P., Petrášová, D. & Svorc, P. Arterial pH and blood gas values in rats under three types of general anesthesia: A chronobiological study. Physiol. Res. 67, 721–728 (2018).
Laporta, M. L., Sprung, J. & Weingarten, T. N. Respiratory depression in the post-anesthesia care unit: Mayo clinic experience. Bosn. J. Basic Med. Sci. 21, 221–228 (2021).
Else, S. D. N. & Kovatsis, P. G. A narrative review of oxygenation during pediatric intubation and airway procedures. Anesth. Analg. 130, 831–840 (2020).
Habre, W. et al. Incidence of severe critical events in paediatric anaesthesia (APRICOT): A prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir. Med. 5, 412–425 (2017).
Morton, D. B. & Griffiths, P. H. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet. Rec. 116, 431–436 (1985).
Gurr, G. T. Biological staining methods. Biol. Stain. Methods. (1952). https://www.cabdirect.org/cabdirect/abstract/19532900366.
Fang, Z., Moser, M. A. J., Zhang, E. M., Zhang, W. & Zhang, B. A novel method to increase tumor ablation zones with rfa by injecting the cationic polymer solution to tissues: In vivo and computational studies. IEEE Trans. Biomed. Eng. 67, 1787–1796 (2020).
Shetty, S., Anushree, U., Kumar, R. & Bharati, S. Electrical conductivity spectra of hepatic tumors reflect hepatocellular carcinoma progression in mice. Biomed. Phys. Eng. Express 6, 065019 (2020).
Marčan, M., Kos, B. & Miklavčič, D. Effect of blood vessel segmentation on the outcome of electroporation-based treatments of liver tumors. PLoS One 10(5), e0125591 (2015).
Acknowledgements
This research was supported by the Spanish government (Ministry of Economy and Competitiveness) under Grants RTI2018-094357-B-C21, RTI2018-094357-B-C22 and Carlos III Health Institute under Grant PI17/0048 and also PI21/00440 from the same institution.
Author information
Authors and Affiliations
Contributions
B.L.A./X.M./M.V.R./O.L./E.B., Data collection, and interpretation, A.H.S., Preparation of the manuscript A.H.S / X.M., Statistical analysis, A.H.S., Preparation of figures. F.B./X.M./O.L., Project supervision. F.B./X.M./O.L./A.A./F.G.A., Design and support of the project. All authors reviewed the definitive version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sarreshtehdari, A., Burdio, F., López-Alonso, B. et al. Preliminary evaluation of the safety and efficacy of glucose solution infusion through the hepatic artery on irreversible electroporation focusing. Sci Rep 13, 7120 (2023). https://doi.org/10.1038/s41598-023-33487-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-33487-3
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.